Healthcare provider profile · identity verified

William Harris, MD

Family Practice · ROANOKE, VA · NPI 1457323594

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	529	154
Atorvastatin Calcium	Atorvastatin Calcium	421	113
Rosuvastatin Calcium	Rosuvastatin Calcium	415	121
Levothyroxine Sodium	Levothyroxine Sodium	300	76
Lisinopril	Lisinopril	279	80
Hydrochlorothiazide	Hydrochlorothiazide	271	80
Pantoprazole Sodium	Pantoprazole Sodium	250	73
Gabapentin	Gabapentin	244	77
Losartan Potassium	Losartan Potassium	215	61
Metformin Hcl	Metformin Hcl	209	57
Oxycodone Hcl	Oxycodone Hcl	202	29
Furosemide	Furosemide	197	59
Alprazolam	Alprazolam	195	42
Omeprazole	Omeprazole	194	63
Duloxetine Hcl	Duloxetine Hcl	170	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	164	43
Albuterol Sulfate Hfa	Albuterol Sulfate	156	53
Escitalopram Oxalate	Escitalopram Oxalate	151	37
Ozempic	Semaglutide	151	26
Carvedilol	Carvedilol	150	43
Sertraline Hcl	Sertraline Hcl	149	47
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	148	23
Allopurinol	Allopurinol	147	40
Metoprolol Tartrate	Metoprolol Tartrate	145	41
Metoprolol Succinate	Metoprolol Succinate	134	41
Trazodone Hcl	Trazodone Hcl	132	39
Pravastatin Sodium	Pravastatin Sodium	122	36
Clonazepam	Clonazepam	119	21
Pregabalin	Pregabalin	111	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	110	31
Tamsulosin Hcl	Tamsulosin Hcl	107	25
Tramadol Hcl	Tramadol Hcl	107	26
Metformin Hcl Er	Metformin Hcl	106	29
Bupropion Xl	Bupropion Hcl	101	27
Fluticasone Propionate	Fluticasone Propionate	101	48
Glipizide Er	Glipizide	98	27
Simvastatin	Simvastatin	98	29
Montelukast Sodium	Montelukast Sodium	97	30
Atenolol	Atenolol	92	25
Lorazepam	Lorazepam	89	18
Meloxicam	Meloxicam	89	28
Potassium Chloride	Potassium Chloride	89	29
Prednisone	Prednisone	85	56
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	28
Pioglitazone Hcl	Pioglitazone Hcl	75	23
Fluoxetine Hcl	Fluoxetine Hcl	74	16
Zolpidem Tartrate	Zolpidem Tartrate	74	26
Eliquis	Apixaban	72	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	67	19
Famotidine	Famotidine	65	22
Alendronate Sodium	Alendronate Sodium	64	17
Diclofenac Sodium	Diclofenac Sodium	64	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	20
Mirtazapine	Mirtazapine	61	19
Baclofen	Baclofen	60	16
Tizanidine Hcl	Tizanidine Hcl	60	24
Warfarin Sodium	Warfarin Sodium	58	17
Ezetimibe	Ezetimibe	57	17
Jardiance	Empagliflozin	57	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	14
Promethazine Hcl	Promethazine Hcl	55	12
Ibuprofen	Ibuprofen	54	13
Clopidogrel	Clopidogrel Bisulfate	53	15
Buspirone Hcl	Buspirone Hcl	51	17
Diazepam	Diazepam	51	18
Donepezil Hcl	Donepezil Hcl	50	14
Methocarbamol	Methocarbamol	50	14
Celecoxib	Celecoxib	49	19
Doxycycline Hyclate	Doxycycline Hyclate	48	31
Triamcinolone Acetonide	Triamcinolone Acetonide	48	35
Meclizine Hcl	Meclizine Hcl	43	19
Propranolol Hcl	Propranolol Hcl	43	13
Amitriptyline Hcl	Amitriptyline Hcl	41	11
Citalopram Hbr	Citalopram Hydrobromide	41	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	suppressed
Lovastatin	Lovastatin	41	13
Morphine Sulfate Er	Morphine Sulfate	41	suppressed
Cephalexin	Cephalexin	40	36
Trulicity	Dulaglutide	40	11
Hydromorphone Hcl	Hydromorphone Hcl	39	suppressed
Ondansetron Odt	Ondansetron	39	18
Rybelsus	Semaglutide	39	11
Fluconazole	Fluconazole	38	22
Mounjaro	Tirzepatide	38	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	38	suppressed
Spironolactone	Spironolactone	38	13
Klor-Con M10	Potassium Chloride	37	15
Novolog Flexpen	Insulin Aspart	37	suppressed
Colchicine	Colchicine	36	12
Ketoconazole	Ketoconazole	34	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Farxiga	Dapagliflozin Propanediol	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	13
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Finasteride	Finasteride	32	suppressed
Chlorthalidone	Chlorthalidone	31	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	13
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	28
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	25
Nitroglycerin	Nitroglycerin	28	12
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	28	15
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	27	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Valsartan	Valsartan	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Azithromycin	Azithromycin	26	24
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Amoxicillin	Amoxicillin	23	16
Acyclovir	Acyclovir	22	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	15
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Topiramate	Topiramate	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	suppressed
Ramelteon	Ramelteon	19	suppressed
Linzess	Linaclotide	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Cefuroxime	Cefuroxime Axetil	17	16
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Liothyronine Sodium	Liothyronine Sodium	17	suppressed
Nystatin	Nystatin	17	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Cefdinir	Cefdinir	15	15
Divalproex Sodium	Divalproex Sodium	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Mupirocin	Mupirocin	14	11
Primidone	Primidone	14	suppressed
Sulindac	Sulindac	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Risperidone	Risperidone	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Valproic Acid	Valproic Acid	12	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed
Lagevrio (Eua)	Molnupiravir	11	11
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error